Sanofi Pasteur announced that it has shipped the first doses of the 2009–2010 formulation of Fluzone (inactivated influenza subvirion vaccine). Sanofi Pasteur expects to supply over 50 million doses of Fluzone in the U.S. for the 2009–2010 influenza season.

Fluzone vaccine is indicated for active immunization in people ≥6 months of age against influenza disease caused by influenza virus subtypes A and type B contained in the seasonal influenza vaccine.

For more information call (800) VACCINE or visit